Biophan tightens grip on MRI (magnetic resonance imaging) safety sector:
This article was originally published in Clinica
In what it claims gives it "market dominance in MRI safety", Biophan Technologies has been issued with a key US patent. The patent, explains the firm, is instrumental in securing the rights to its "anti-antenna" technology for making a broad range of medical apparatus - including pacemakers, surgical tools, and cardiovascular stents - safe for use with MRI systems. "Safety and image compatibility have long been major concerns when considering use of MRI ... with implanted devices," said Michael Weiner, the West Henrietta, New York firm's CEO. "We anticipate that this patent will protect the company's technology against the efforts of any other companies to make devices, such as pacemakers and neurostimulators, definitively safe for use with MRI machines."